You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nonreplicating adenovirus

Showing 1 - 25 of 291
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Myrtle Beach (ChAdOx1-PCAQ, MVA-PCAQ)

Recruiting
  • Prostate Cancer
  • ChAdOx1-PCAQ
  • MVA-PCAQ
  • Myrtle Beach, South Carolina
    Carolina Urologic Research Center
Jan 30, 2023

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

Not yet recruiting
  • Adenovirus
  • +2 more
  • Specific T- Lymphocytes
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 8, 2023

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

Recruiting
  • Malignant Pleural Mesothelioma, Advanced
  • Oncolytic Adenovirus H101
  • Programmed death receptor-1 inhibitor
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 2, 2023

Bladder Cancer Trial in Hangzhou (H101, Camrelizumab)

Recruiting
  • Bladder Cancer
  • H101, Camrelizumab
  • Hangzhou, Zhejiang, China
    Hua Wang
Oct 2, 2022

Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

Recruiting
  • Adenovirus Infection
  • Adenovirus Specific T lymphocytes
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 1, 2022

COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For

Recruiting
  • COVID-19
  • Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 1, 2023

Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Adenovirus
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +8 more
Sep 27, 2022

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

Hemophilia A, Gene Therapy, Clotting Disorders Trial in Johannesburg, London, Southampton (Valoctocogene Roxaparvovec)

Recruiting
  • Hemophilia A
  • +3 more
  • Valoctocogene Roxaparvovec
  • Seoul, Korea, Republic of
  • +8 more
Jan 6, 2023

COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
  • Taizhou, Jiangsu, China
    Taixing City center for Disease Control and Prevention
Oct 28, 2022

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)

Recruiting
  • Refractory Angina Pectoris
  • +2 more
  • Copenhagen, Denmark
  • +1 more
Oct 19, 2022

Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant L-IFN adenovirus injection
  • Shanghai, Shanghai, China
    Shanghai Fengxian District Central Hospital
Jan 16, 2022

COVID-19 Trial in Singapore (Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation)

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation
  • Singapore, Singapore
    National University Hospital
Jan 29, 2023

COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Spain (COVID-19 Vaccine HIPRA 40 ug/dose, Comirnaty (Pfizer-BioNtech) 30

Recruiting
  • COVID-19
  • SARS-CoV-2 Acute Respiratory Disease
  • COVID-19 Vaccine HIPRA 40 ug/dose
  • Comirnaty (Pfizer-BioNtech) 30 ug/dose concentrate for dispersion for injection
  • Coruña, Spain
  • +6 more
Jul 21, 2022

Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

Recruiting
  • Platinum-refractory Ovarian Carcinoma
  • Platinum-resistant Ovarian Cancer
  • TILT-123
  • Pembrolizumab
  • Rochester, Minnesota
  • +1 more
Aug 12, 2022

Recurring Glioblastoma Trial in Fujian (Recombinant L-IFN adenovirus injection)

Recruiting
  • Recurring Glioblastoma
  • Recombinant L-IFN adenovirus injection
  • Fujian, Fujian, China
    Binhai Hospital of Fujian Medical University
Jun 27, 2023

Adenovirus Infection in Children With Autoimmune Hepatitis

Not yet recruiting
  • Observational
  • Pcr
  • (no location specified)
Jan 20, 2023

Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Recombinant Human Adenovirus Type 5
  • HAIC of FOLFOX
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Mar 16, 2022

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022

Viral Infections After HSCT Trial in Washington (VSTs)

Active, not recruiting
  • Viral Infections After HSCT
  • VSTs
  • Washington, District of Columbia
    Childrens National Medical Center
Aug 30, 2022

Adenovirus Infection Trial in United States (BCV)

Recruiting
  • Adenovirus Infection
  • Los Angeles, California
  • +10 more
May 24, 2022